Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-16

Clinical Trial Update: Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Hayfever With or Without Asthma (P03472) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effectiveness and safety of desloratadine syrup in children with seasonal allergic rhinitis with or without asthma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desloratadine (Aerius) syrup (desloratadine)

Snippet

Sponsor: Organon and Co | Conditions: Rhinitis, Allergic, Seasonal, Asthma | Phase 3 | Status: COMPLETED